The science of genomics is at the beginning of a new era of innovation. The rapidly declining cost of gene sequencing is making huge amounts of genetic data available, and the full power of information technology is being applied to vastly speed up the process of analyzing these data to discover how genes determine traits or mutate to cause disease.
The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers to develop strategies to attract and retain this new segment of customers.
Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.
Making sense of e-detailing in Japan’s pharmaceutical sector
For decades, pharmaceutical companies had a simple business model. They hired thousands of sales reps who would hustle from door-to-door, desperate to win a few minutes time from physicians to attempt to convince them why Product A had superior efficacy and/or fewer side effects than Product B. The practice, which has changed little over the years, is unwieldy and inefficient. Is there a better way?
If you haven’t been living under a rock then you’ve most likely heard that Iran and the P5+1 have reached a historic long-term comprehensive nuclear deal that will prevent Iran from acquiring a nuclear weapon in exchange for lifting economic sanctions and enabling Iran to join the world economic system.
(Plymouth, MI) – As an ever growing company, EPIC Translations has countlessly confirmed the value they add to both early and mature businesses when wanting to attain global market share. They offer vital support to company goals such as expansion and growth in the global marketplace.